| Literature DB >> 29691324 |
Eddie C Y Wang1, Mariana Pjechova2,3, Katie Nightingale4, Virginia-Maria Vlahava2, Mihil Patel2, Eva Ruckova2,3, Simone K Forbes2, Luis Nobre4, Robin Antrobus4, Dawn Roberts2, Ceri A Fielding2, Sepehr Seirafian2, James Davies2, Isa Murrell2, Betty Lau5, Gavin S Wilkie5, Nicolás M Suárez5, Richard J Stanton2, Borivoj Vojtesek3, Andrew Davison5, Paul J Lehner4, Michael P Weekes4, Gavin W G Wilkinson2, Peter Tomasec2.
Abstract
CD58 is an adhesion molecule that is known to play a critical role in costimulation of effector cells and is intrinsic to immune synapse structure. Herein, we describe a virally encoded gene that inhibits CD58 surface expression. Human cytomegalovirus (HCMV) UL148 was necessary and sufficient to promote intracellular retention of CD58 during HCMV infection. Blocking studies with antagonistic anti-CD58 mAb and an HCMV UL148 deletion mutant (HCMV∆UL148) with restored CD58 expression demonstrated that the CD2/CD58 axis was essential for the recognition of HCMV-infected targets by CD8+ HCMV-specific cytotoxic T lymphocytes (CTLs). Further, challenge of peripheral blood mononuclear cells ex vivo with HCMV∆UL148 increased both CTL and natural killer (NK) cell degranulation against HCMV-infected cells, including NK-driven antibody-dependent cellular cytotoxicity, showing that UL148 is a modulator of the function of multiple effector cell subsets. Our data stress the effect of HCMV immune evasion functions on shaping the immune response, highlighting the capacity for their potential use in modulating immunity during the development of anti-HCMV vaccines and HCMV-based vaccine vectors.Entities:
Keywords: CD58; CTLs; NK cells; human cytomegalovirus; immune modulation
Mesh:
Substances:
Year: 2018 PMID: 29691324 PMCID: PMC5948980 DOI: 10.1073/pnas.1720950115
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 12.779